PlainRecalls
ModerateClass IITerminated

FDA Drug recall · Reported September 22, 2021

MIC+Methyl B12 injection Methionine Inositol Choline+Methylcobalamin 25 mg/50 mg/50 mg/1 mg/mL, 10 mL vial sterile, Rx only, Promise Pharmacy 31818 US Hwy 19N Palm Harbor FL 34684 1-888-3PROMIS

Lack of processing controls

Recall #
D-0803-2021
Affected scope
57 vials
Initiated
June 30, 2021
Compiled from official public sources by the editorial team.
Verify with FDA Drug →
View my saved recalls

Promise Pharmacy, LLC recalled MIC+Methyl B12 injection Methionine Inositol Choline+Methylcobalamin 25 mg/50 mg/50 mg/1 … - a moderate-severity action.

MIC+Methyl B12 injection Methionine Inositol Choline+Methylcobalamin 25 mg/50 mg/50 mg/1 … was recalled by Promise Pharmacy, LLC in September 22, 2021. Reason: Lack of processing controls. Check the official notice for the remedy. Verify recall #D-0803-2021 with the FDA Drug before acting.

The recall

Promise Pharmacy, LLC issued this moderate-severity FDA Drug recall-Lack of processing controls.

Moderate
severity level
Class II
classification
September 22, 2021
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0803-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-0803-2021) was formally reported on September 22, 2021, with the manufacturer initiating the action on June 30, 2021. It is classified under Moderate severity (Class II), with a current status of Terminated. Promise Pharmacy, LLC is listed as the recalling firm, operating out of Palm Harbor, FL. Federal records list the affected scope as 57 vials.

The documented reason for this recall is: Lack of processing controls Distribution data in the federal record shows the product reached: AZ, CO, FL, IL, NJ. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Drugs & Medications recalls over time

Where this recall sits in its category - 14,287 drugs & medications recalls on record

-50005001,0001,5002,000 2006201220152018202120242026 263
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

57 vials

Related Recalls

6

5 from same agency

Product description

MIC+Methyl B12 injection Methionine Inositol Choline+Methylcobalamin 25 mg/50 mg/50 mg/1 mg/mL, 10 mL vial sterile, Rx only, Promise Pharmacy 31818 US Hwy 19N Palm Harbor FL 34684 1-888-3PROMIS

Reason for recall

Lack of processing controls

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Terminated
Recall number D-0803-2021
Date reported September 22, 2021
Date initiated June 30, 2021
Recalling firm Promise Pharmacy, LLC
Firm location Palm Harbor, FL
Affected scope 57 vials
Distribution AZ, CO, FL, IL, NJ

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0803-2021) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
MIC+Methyl B12 injection Methionine Inositol Choline+Methylcobalamin 25 mg/50 mg/50 mg/1 mg/mL, 10 mL vial sterile, Rx only, Promise Pharmacy 31818 US Hwy 19N Palm Harbor FL 34684 1-888-3PROMIS. Recalled by Promise Pharmacy, LLC. Units affected: 57 vials.
Why was this product recalled?
Lack of processing controls
Which agency issued this recall?
This recall was issued by the FDA Drug on September 22, 2021. Severity: Moderate. Recall number: D-0803-2021.
Where was the recalled product distributed?
Distribution: AZ, CO, FL, IL, NJ.
How do I check if my product is affected by a recall?
Check the product description and recall number (D-0803-2021) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →

Browse all Drugs & Medications recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported September 22, 2021. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.